報價延遲最少15分鐘:2025/04/29 16:18 EDT
|
|
|
|
|
||||||||||||
|
|
|
|
|
56.31 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-1.75/-1.27
|
|
企業價值
3.05B
|
| 資產負債 |
|
每股賬面淨值
7.10
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
224.50M
|
|
每股收益
2.12
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/04/29 16:18 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S. |